Development of myelodysplastic syndrome evolving to acute myeloid leukemia in a patient receiving etanercept for psoriasis

J Am Acad Dermatol. 2011 Sep;65(3):673-674. doi: 10.1016/j.jaad.2010.06.049.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Etanercept
  • Humans
  • Immunoglobulin G / adverse effects*
  • Immunoglobulin G / therapeutic use
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / therapeutic use
  • Leukemia, Myeloid, Acute / chemically induced*
  • Male
  • Myelodysplastic Syndromes / chemically induced*
  • Psoriasis / drug therapy*
  • Receptors, Tumor Necrosis Factor / therapeutic use

Substances

  • Immunoglobulin G
  • Immunosuppressive Agents
  • Receptors, Tumor Necrosis Factor
  • Etanercept